SCHEMBL6402288

SCHEMBL6402288

CC(Cc1c(O)cc(O)cc1P(=O)(O)O)c1cccc(O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
ADRB1 P08588 2/20 0.37
ADRA1A P35348 2/20 0.37
MIF P14174 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2B P41595 1/20 0.37
HIF1A Q16665 4/20 0.35
ADRB2 P07550 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRB3 P13945 1/20 0.35
TSHR P16473 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
NFKB1 P19838 1/20 0.35
DRD1 P21728 1/20 0.35
HTR7 P34969 1/20 0.35
ADRA1B P35368 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6402836 0.88 HDAC4 (0.41) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6401217 0.87 HDAC4 (0.36) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6396759 0.85 ESR1 (0.46) ADRB1ADRA1AMIFHTR2AHIF1A
SCHEMBL6397731 0.85 SLC22A1 (0.36) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6396467 0.81 ADRB1 (0.39) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6398304 0.81 HDAC4 (0.35) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6402286 0.81 HIF1A (0.35) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6398358 0.79 HIF1A (0.39) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6399427 0.79 FFAR1 (0.35) HDAC4HDAC2HDAC8ADRB1ADRA1A
SCHEMBL6396070 0.79 ADRB1 (0.38) HDAC4HDAC2HDAC8ADRB1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed
EP-1175425-A2 INHIBITORS OF INTESTINAL APICAL MEMBRANE NA/PHOSPHATE CO-TRANSPORTATION THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2002-01-30 EP disclosed
WO-2000043402-A2 INHIBITORS OF INTESTINAL APICAL MEMBRANE NA/PHOSPHATE CO-TRANSPORTATION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HDAC4 3531/4885HDAC2 4401/4885HDAC8 4478/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 HDAC4 3433/4885HDAC2 4287/4885HDAC8 4316/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 HDAC4 3531/4885HDAC2 4401/4885HDAC8 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.